HealthEquity EPS - Earnings per Share 2014-2024 | HQY
HealthEquity annual and quarterly earnings per share history from 2014 to 2024. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
- HealthEquity EPS for the quarter ending January 31, 2024 was $0.30, a INF% increase year-over-year.
- HealthEquity EPS for the twelve months ending January 31, 2024 was $0.64, a 306.45% decline year-over-year.
- HealthEquity 2024 annual EPS was $0.64, a 306.45% decline from 2023.
- HealthEquity 2023 annual EPS was $-0.31, a 41.51% decline from 2022.
- HealthEquity 2022 annual EPS was $-0.53, a 541.67% decline from 2021.
| HealthEquity Annual EPS | |
|---|---|
| 2024 | $0.64 |
| 2023 | $-0.31 |
| 2022 | $-0.53 |
| 2021 | $0.12 |
| 2020 | $0.58 |
| 2019 | $1.17 |
| 2018 | $0.77 |
| 2017 | $0.44 |
| 2016 | $0.28 |
| 2015 | $0.21 |
| 2014 | $-1.26 |
| 2013 | $0.25 |
| HealthEquity Quarterly EPS | |
|---|---|
| 2024-01-31 | $0.30 |
| 2023-10-31 | $0.17 |
| 2023-07-31 | $0.12 |
| 2023-04-30 | $0.05 |
| 2023-01-31 | $0.00 |
| 2022-10-31 | $-0.02 |
| 2022-07-31 | $-0.13 |
| 2022-04-30 | $-0.16 |
| 2022-01-31 | $-0.39 |
| 2021-10-31 | $-0.06 |
| 2021-07-31 | $-0.05 |
| 2021-04-30 | $-0.03 |
| 2021-01-31 | $0.07 |
| 2020-10-31 | $0.02 |
| 2020-07-31 | $0.00 |
| 2020-04-30 | $0.03 |
| 2020-01-31 | $-0.07 |
| 2019-10-31 | $-0.30 |
| 2019-07-31 | $0.30 |
| 2019-04-30 | $0.65 |
| 2019-01-31 | $0.20 |
| 2018-10-31 | $0.25 |
| 2018-07-31 | $0.36 |
| 2018-04-30 | $0.36 |
| 2018-01-31 | $0.10 |
| 2017-10-31 | $0.17 |
| 2017-07-31 | $0.27 |
| 2017-04-30 | $0.23 |
| 2017-01-31 | $0.06 |
| 2016-10-31 | $0.10 |
| 2016-07-31 | $0.14 |
| 2016-04-30 | $0.14 |
| 2016-01-31 | $0.04 |
| 2015-10-31 | $0.07 |
| 2015-07-31 | $0.08 |
| 2015-04-30 | $0.09 |
| 2015-01-31 | $0.02 |
| 2014-10-31 | $0.05 |
| 2014-07-31 | $0.06 |
| 2014-04-30 | $0.08 |
| 2014-01-31 | $0.00 |
| 2013-10-31 | $0.04 |
| 2013-07-31 | $0.05 |
| 2013-01-31 | $0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $7.177B | $1.000B |
| HealthEquity provides integrated solutions for health-care account management, health reimbursement arrangement and flexible spending accounts for health plans, insurance companies and third-party administrators in the United States. HealthEquity's flagship health savings account or HSA is a financial account through which consumers spend and save for the long term for healthcare on a tax-advantaged basis. This has provided the company with a competitive edge in the MedTech industry. Other than HSAs, the company offers Healthcare saving and spending platform, Investment platform and advisory services and Reimbursement arrangements. In addition, HealthEquity offers health reimbursement and flexible spending arrangements solutions; Employee Retirement Income Security Act's plan administration and investment services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $124.299B | 15.60 |
| Cencora (COR) | United States | $46.379B | 18.08 |
| ICON (ICLR) | Ireland | $25.848B | 24.40 |
| DiDi Global (DIDIY) | China | $20.706B | 0.00 |
| Avantor (AVTR) | United States | $14.726B | 21.68 |
| CochLear (CHEOY) | Australia | $13.973B | 0.00 |
| Natera (NTRA) | United States | $13.533B | 0.00 |
| Revvity (RVTY) | United States | $13.407B | 23.52 |
| Medpace Holdings (MEDP) | United States | $12.205B | 40.15 |
| Viatris (VTRS) | United States | $12.109B | 3.62 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $10.989B | 0.00 |
| Charles River Laboratories (CRL) | United States | $10.790B | 20.66 |
| Solventum (SOLV) | United States | $9.423B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $7.951B | 0.00 |
| Doximity (DOCS) | United States | $5.537B | 38.78 |
| Bausch + Lomb (BLCO) | Canada | $5.309B | 21.25 |
| Organon (OGN) | United States | $5.246B | 4.98 |
| PACS (PACS) | United States | $4.392B | 0.00 |
| Life Times (LTH) | United States | $3.563B | 37.33 |
| Sotera Health (SHC) | United States | $3.281B | 16.10 |
| GoodRx Holdings (GDRX) | United States | $3.193B | 121.57 |
| Surgery Partners (SGRY) | United States | $3.177B | 29.07 |
| Agilon Health (AGL) | United States | $2.838B | 0.00 |
| Progyny (PGNY) | United States | $2.569B | 44.23 |
| NovoCure (NVCR) | Jersey | $2.296B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.102B | 8.33 |
| Premier (PINC) | United States | $1.927B | 8.24 |
| BrightSpring Health Services (BTSG) | United States | $1.794B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.696B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $1.591B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.566B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.224B | 0.00 | |
| GeneDx Holdings (WGS) | United States | $0.752B | 0.00 |
| CareDx (CDNA) | United States | $0.739B | 0.00 |
| Embecta (EMBC) | United States | $0.738B | 5.02 |
| InnovAge Holding (INNV) | United States | $0.691B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.609B | 6.46 |
| Auna S.A (AUNA) | Luxembourg | $0.600B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.583B | 15.27 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.455B | 0.00 |
| Enhabit (EHAB) | United States | $0.441B | 44.00 |
| ModivCare (MODV) | United States | $0.375B | 7.02 |
| Sonida Senior Living (SNDA) | United States | $0.369B | 0.00 |
| LifeMD (LFMD) | United States | $0.329B | 0.00 |
| DocGo (DCGO) | United States | $0.294B | 16.06 |
| Sharecare (SHCR) | United States | $0.292B | 0.00 |
| MultiPlan (MPLN) | United States | $0.281B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.261B | 0.00 |
| Beauty Health (SKIN) | United States | $0.244B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.196B | 0.00 |
| Biodesix (BDSX) | United States | $0.184B | 0.00 |
| So-Young (SY) | China | $0.114B | 55.25 |
| Pono Capital Two (PTWO) | United States | $0.072B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.050B | 0.00 |
| NeueHealth (NEUE) | United States | $0.044B | 5.99 |
| IceCure Medical (ICCM) | Israel | $0.037B | 0.00 |
| Oncology Institute (TOI) | United States | $0.034B | 0.00 |
| Nutex Health (NUTX) | United States | $0.027B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.027B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.024B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.024B | 0.00 |
| OncoCyte (OCX) | United States | $0.023B | 0.00 |
| KindlyMD (KDLY) | $0.016B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| DermTech (DMTK) | United States | $0.011B | 0.00 |
| XWELL (XWEL) | United States | $0.011B | 0.00 |
| TRxADE HEALTH (MEDS) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.004B | 0.00 |
| OpGen (OPGN) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Assure Holdings (IONM) | United States | $0.002B | 0.00 |